These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8570772)

  • 1. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men.
    Meltzer HY; Maes M
    Psychiatry Res; 1995 Sep; 58(2):89-98. PubMed ID: 8570772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men.
    Meltzer HY; Maes M
    Biol Psychiatry; 1995 Sep; 38(5):310-8. PubMed ID: 7495925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.
    Meltzer HY; Maes M
    Psychopharmacology (Berl); 1994 May; 114(4):635-43. PubMed ID: 7855226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pindolol on hormone secretion and body temperature: partial agonist effects.
    Meltzer HY; Maes M
    J Neural Transm (Vienna); 1996; 103(1-2):77-88. PubMed ID: 9026379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
    Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine.
    Sevy S; Brown SL; Wetzler S; Kotler M; Molcho A; Plutchik R; van Praag HM
    Psychiatry Res; 1994 Sep; 53(3):219-29. PubMed ID: 7870844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):222-30. PubMed ID: 7659770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
    Silverstone PH; Cowen PJ
    Biol Psychiatry; 1994 Sep; 36(5):309-16. PubMed ID: 7993957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists.
    Lesch KP; Söhnle K; Poten B; Schoellnhammer G; Rupprecht R; Schulte HM
    J Clin Endocrinol Metab; 1990 Mar; 70(3):670-4. PubMed ID: 1968468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors.
    Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Murphy DL
    Psychopharmacology (Berl); 1996 Feb; 123(4):333-9. PubMed ID: 8867872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.
    Gibson EL; Barnfield AM; Curzon G
    Neuropharmacology; 1994; 33(3-4):457-65. PubMed ID: 7984284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS; Westenberg HG
    J Psychiatr Res; 2008 Sep; 42(11):894-901. PubMed ID: 18533183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
    Willins DL; Meltzer HY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats.
    Yamada J; Sugimoto Y
    Eur J Pharmacol; 2000 Oct; 406(1):153-7. PubMed ID: 11011047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of 5-HT2C receptors in the m-CPP-induced antinociception in mice.
    Chojnacka-Wójcik E; Kłodzińska A; Dereń-Wesołek A
    Pol J Pharmacol; 1994; 46(5):423-8. PubMed ID: 7894529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test.
    Leone M; Attanasio A; Croci D; Ferraris A; D'Amico D; Grazzi L; Nespolo A; Bussone G
    Neuroreport; 1998 Aug; 9(11):2605-8. PubMed ID: 9721941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Helsley S; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man.
    Palazidou E; Stephenson J; Butler J; Coskeran P; Chambers S; McGregor AM
    Psychopharmacology (Berl); 1995 Jun; 119(3):311-4. PubMed ID: 7675967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.